Defence Therapeutics Inc (DTC.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Operating Expenses | 3,269 | 12,822 | 6,545 | 7,320 | 2,859 |
| Operating Income | -3,269 | -12,822 | -6,545 | -7,320 | -2,859 |
| Interest Expense | 323 | 398 | 263 | N/A | N/A |
| Other Income | 69 | 27 | -59 | 24 | 0 |
| Pre-tax Income | -3,522 | -13,193 | -6,868 | -7,296 | -2,859 |
| Income Tax | N/A | 0 | -105 | N/A | N/A |
| Net Income Continuous | -3,522 | -13,193 | -6,763 | -7,296 | -2,859 |
| Net Income | $-3,522 | $-13,193 | $-6,763 | $-7,344 | $-2,859 |
| EPS Basic Total Ops | -0.07 | -0.30 | -0.17 | -0.20 | -0.11 |
| EPS Basic Continuous Ops | -0.07 | -0.30 | -0.17 | -0.20 | -0.11 |
| EPS Diluted Total Ops | -0.07 | -0.30 | -0.17 | -0.20 | -0.11 |
| EPS Diluted Continuous Ops | -0.07 | -0.30 | -0.17 | -0.20 | -0.11 |
| EBITDA(a) | $-3,127 | $-12,704 | $-6,591 | $-7,320 | $-2,859 |